GO:0008150 | biological_process | 93.1% (81/87) | 0.6 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 91.95% (80/87) | 0.59 | 0.0 | 0.0 |
GO:0031090 | organelle membrane | 41.38% (36/87) | 1.69 | 0.0 | 0.0 |
GO:0016020 | membrane | 62.07% (54/87) | 1.14 | 0.0 | 0.0 |
GO:0031984 | organelle subcompartment | 20.69% (18/87) | 2.76 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 90.8% (79/87) | 0.59 | 0.0 | 0.0 |
GO:0016050 | vesicle organization | 11.49% (10/87) | 3.82 | 0.0 | 1e-06 |
GO:0016032 | viral process | 10.34% (9/87) | 4.15 | 0.0 | 1e-06 |
GO:0003674 | molecular_function | 88.51% (77/87) | 0.57 | 0.0 | 1e-06 |
GO:0030659 | cytoplasmic vesicle membrane | 14.94% (13/87) | 3.04 | 0.0 | 2e-06 |
GO:0098588 | bounding membrane of organelle | 28.74% (25/87) | 1.88 | 0.0 | 2e-06 |
GO:0050794 | regulation of cellular process | 58.62% (51/87) | 1.01 | 0.0 | 2e-06 |
GO:0012506 | vesicle membrane | 14.94% (13/87) | 2.98 | 0.0 | 2e-06 |
GO:0010008 | endosome membrane | 11.49% (10/87) | 3.55 | 0.0 | 2e-06 |
GO:0009987 | cellular process | 81.61% (71/87) | 0.64 | 0.0 | 2e-06 |
GO:0050789 | regulation of biological process | 63.22% (55/87) | 0.91 | 0.0 | 2e-06 |
GO:0065007 | biological regulation | 66.67% (58/87) | 0.86 | 0.0 | 2e-06 |
GO:0005515 | protein binding | 67.82% (59/87) | 0.84 | 0.0 | 2e-06 |
GO:0005488 | binding | 79.31% (69/87) | 0.66 | 0.0 | 2e-06 |
GO:0032879 | regulation of localization | 21.84% (19/87) | 2.19 | 0.0 | 3e-06 |
GO:0098791 | Golgi apparatus subcompartment | 14.94% (13/87) | 2.81 | 0.0 | 5e-06 |
GO:0071705 | nitrogen compound transport | 21.84% (19/87) | 2.14 | 0.0 | 5e-06 |
GO:0046907 | intracellular transport | 18.39% (16/87) | 2.41 | 0.0 | 5e-06 |
GO:0005802 | trans-Golgi network | 13.79% (12/87) | 2.94 | 0.0 | 6e-06 |
GO:0051649 | establishment of localization in cell | 19.54% (17/87) | 2.27 | 0.0 | 7e-06 |
GO:0051234 | establishment of localization | 33.33% (29/87) | 1.52 | 0.0 | 8e-06 |
GO:0006906 | vesicle fusion | 6.9% (6/87) | 4.75 | 0.0 | 1e-05 |
GO:0048232 | male gamete generation | 9.2% (8/87) | 3.81 | 0.0 | 1e-05 |
GO:0016197 | endosomal transport | 9.2% (8/87) | 3.79 | 0.0 | 1.1e-05 |
GO:0006810 | transport | 32.18% (28/87) | 1.54 | 0.0 | 1.1e-05 |
GO:0051179 | localization | 35.63% (31/87) | 1.42 | 0.0 | 1.1e-05 |
GO:0043229 | intracellular organelle | 67.82% (59/87) | 0.76 | 0.0 | 1.1e-05 |
GO:0090174 | organelle membrane fusion | 6.9% (6/87) | 4.65 | 0.0 | 1.2e-05 |
GO:0043226 | organelle | 67.82% (59/87) | 0.76 | 0.0 | 1.2e-05 |
GO:0061024 | membrane organization | 12.64% (11/87) | 2.97 | 0.0 | 1.2e-05 |
GO:0071702 | organic substance transport | 22.99% (20/87) | 1.95 | 0.0 | 1.2e-05 |
GO:0031224 | intrinsic component of membrane | 28.74% (25/87) | 1.65 | 0.0 | 1.2e-05 |
GO:0007276 | gamete generation | 10.34% (9/87) | 3.37 | 0.0 | 1.6e-05 |
GO:0016021 | integral component of membrane | 26.44% (23/87) | 1.72 | 0.0 | 1.6e-05 |
GO:0048522 | positive regulation of cellular process | 35.63% (31/87) | 1.36 | 0.0 | 1.8e-05 |
GO:0001837 | epithelial to mesenchymal transition | 4.6% (4/87) | 6.11 | 0.0 | 2.1e-05 |
GO:0048518 | positive regulation of biological process | 40.23% (35/87) | 1.22 | 0.0 | 2.3e-05 |
GO:0060341 | regulation of cellular localization | 12.64% (11/87) | 2.84 | 0.0 | 2.5e-05 |
GO:0051128 | regulation of cellular component organization | 21.84% (19/87) | 1.91 | 0.0 | 2.7e-05 |
GO:0016192 | vesicle-mediated transport | 14.94% (13/87) | 2.51 | 0.0 | 2.7e-05 |
GO:0061025 | membrane fusion | 6.9% (6/87) | 4.39 | 0.0 | 2.8e-05 |
GO:0005829 | cytosol | 35.63% (31/87) | 1.32 | 1e-06 | 3e-05 |
GO:0006996 | organelle organization | 25.29% (22/87) | 1.7 | 1e-06 | 3.4e-05 |
GO:0051130 | positive regulation of cellular component organization | 12.64% (11/87) | 2.75 | 1e-06 | 4.1e-05 |
GO:0032880 | regulation of protein localization | 11.49% (10/87) | 2.94 | 1e-06 | 4.1e-05 |
GO:0048762 | mesenchymal cell differentiation | 4.6% (4/87) | 5.81 | 1e-06 | 4.1e-05 |
GO:0032502 | developmental process | 51.72% (45/87) | 0.94 | 1e-06 | 4.4e-05 |
GO:0046786 | viral replication complex formation and maintenance | 3.45% (3/87) | 7.23 | 1e-06 | 4.5e-05 |
GO:0090150 | establishment of protein localization to membrane | 8.05% (7/87) | 3.7 | 1e-06 | 6.1e-05 |
GO:0031300 | intrinsic component of organelle membrane | 9.2% (8/87) | 3.35 | 1e-06 | 6.2e-05 |
GO:0015031 | protein transport | 14.94% (13/87) | 2.36 | 1e-06 | 6.7e-05 |
GO:0006605 | protein targeting | 9.2% (8/87) | 3.32 | 1e-06 | 7e-05 |
GO:0048193 | Golgi vesicle transport | 9.2% (8/87) | 3.28 | 2e-06 | 8.2e-05 |
GO:0051668 | localization within membrane | 10.34% (9/87) | 3.02 | 2e-06 | 8.3e-05 |
GO:0031410 | cytoplasmic vesicle | 19.54% (17/87) | 1.91 | 2e-06 | 9.9e-05 |
GO:0006886 | intracellular protein transport | 12.64% (11/87) | 2.58 | 2e-06 | 0.0001 |
GO:0031982 | vesicle | 20.69% (18/87) | 1.81 | 3e-06 | 0.000115 |
GO:0045184 | establishment of protein localization | 14.94% (13/87) | 2.27 | 3e-06 | 0.000117 |
GO:0043227 | membrane-bounded organelle | 59.77% (52/87) | 0.76 | 3e-06 | 0.000118 |
GO:0097708 | intracellular vesicle | 19.54% (17/87) | 1.86 | 3e-06 | 0.000133 |
GO:0051640 | organelle localization | 10.34% (9/87) | 2.9 | 3e-06 | 0.000139 |
GO:0072657 | protein localization to membrane | 9.2% (8/87) | 3.15 | 4e-06 | 0.000139 |
GO:0030301 | cholesterol transport | 4.6% (4/87) | 5.29 | 3e-06 | 0.00014 |
GO:0008104 | protein localization | 17.24% (15/87) | 2.01 | 4e-06 | 0.00015 |
GO:0031301 | integral component of organelle membrane | 8.05% (7/87) | 3.4 | 5e-06 | 0.00018 |
GO:0060627 | regulation of vesicle-mediated transport | 9.2% (8/87) | 3.08 | 5e-06 | 0.00019 |
GO:0043231 | intracellular membrane-bounded organelle | 58.62% (51/87) | 0.75 | 5e-06 | 0.000197 |
GO:0051049 | regulation of transport | 16.09% (14/87) | 2.05 | 6e-06 | 0.000229 |
GO:0033043 | regulation of organelle organization | 12.64% (11/87) | 2.41 | 7e-06 | 0.000251 |
GO:0001893 | maternal placenta development | 3.45% (3/87) | 6.31 | 7e-06 | 0.000252 |
GO:0048284 | organelle fusion | 6.9% (6/87) | 3.68 | 8e-06 | 0.00028 |
GO:0048519 | negative regulation of biological process | 34.48% (30/87) | 1.17 | 8e-06 | 0.000283 |
GO:0007399 | nervous system development | 5.75% (5/87) | 4.13 | 1e-05 | 0.000355 |
GO:0051641 | cellular localization | 19.54% (17/87) | 1.73 | 1.2e-05 | 0.000366 |
GO:0032991 | protein-containing complex | 29.89% (26/87) | 1.27 | 1.2e-05 | 0.00037 |
GO:0048471 | perinuclear region of cytoplasm | 9.2% (8/87) | 2.92 | 1.1e-05 | 0.000374 |
GO:0007283 | spermatogenesis | 6.9% (6/87) | 3.59 | 1.1e-05 | 0.000374 |
GO:0048856 | anatomical structure development | 40.23% (35/87) | 1.01 | 1.1e-05 | 0.000377 |
GO:0009504 | cell plate | 5.75% (5/87) | 4.11 | 1.1e-05 | 0.000377 |
GO:0033036 | macromolecule localization | 18.39% (16/87) | 1.8 | 1.2e-05 | 0.000378 |
GO:0045727 | positive regulation of translation | 6.9% (6/87) | 3.57 | 1.2e-05 | 0.00038 |
GO:0071840 | cellular component organization or biogenesis | 36.78% (32/87) | 1.08 | 1.3e-05 | 0.000383 |
GO:0008333 | endosome to lysosome transport | 4.6% (4/87) | 4.79 | 1.4e-05 | 0.000414 |
GO:0070727 | cellular macromolecule localization | 17.24% (15/87) | 1.86 | 1.4e-05 | 0.000418 |
GO:0036211 | protein modification process | 26.44% (23/87) | 1.38 | 1.4e-05 | 0.000419 |
GO:0032940 | secretion by cell | 6.9% (6/87) | 3.51 | 1.5e-05 | 0.000447 |
GO:0016462 | pyrophosphatase activity | 9.2% (8/87) | 2.83 | 1.7e-05 | 0.000502 |
GO:0140056 | organelle localization by membrane tethering | 4.6% (4/87) | 4.7 | 1.8e-05 | 0.000503 |
GO:0120025 | plasma membrane bounded cell projection | 13.79% (12/87) | 2.14 | 1.8e-05 | 0.000504 |
GO:0032592 | integral component of mitochondrial membrane | 4.6% (4/87) | 4.68 | 1.9e-05 | 0.000527 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 9.2% (8/87) | 2.81 | 1.9e-05 | 0.000531 |
GO:0048523 | negative regulation of cellular process | 27.59% (24/87) | 1.3 | 2.1e-05 | 0.000569 |
GO:0016482 | cytosolic transport | 5.75% (5/87) | 3.92 | 2.1e-05 | 0.000569 |
GO:0051701 | biological process involved in interaction with host | 5.75% (5/87) | 3.91 | 2.2e-05 | 0.000582 |
GO:0022406 | membrane docking | 4.6% (4/87) | 4.62 | 2.2e-05 | 0.000591 |
GO:0010634 | positive regulation of epithelial cell migration | 4.6% (4/87) | 4.6 | 2.3e-05 | 0.000611 |
GO:0010638 | positive regulation of organelle organization | 8.05% (7/87) | 3.05 | 2.3e-05 | 0.000614 |
GO:0045202 | synapse | 9.2% (8/87) | 2.77 | 2.4e-05 | 0.000624 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 9.2% (8/87) | 2.76 | 2.5e-05 | 0.000635 |
GO:0034250 | positive regulation of cellular amide metabolic process | 6.9% (6/87) | 3.39 | 2.5e-05 | 0.00064 |
GO:0048609 | multicellular organismal reproductive process | 12.64% (11/87) | 2.21 | 2.6e-05 | 0.000643 |
GO:0072396 | response to cell cycle checkpoint signaling | 3.45% (3/87) | 5.7 | 2.7e-05 | 0.000653 |
GO:0072402 | response to DNA integrity checkpoint signaling | 3.45% (3/87) | 5.7 | 2.7e-05 | 0.000653 |
GO:0072423 | response to DNA damage checkpoint signaling | 3.45% (3/87) | 5.7 | 2.7e-05 | 0.000653 |
GO:1903828 | negative regulation of protein localization | 5.75% (5/87) | 3.85 | 2.7e-05 | 0.000653 |
GO:0016043 | cellular component organization | 34.48% (30/87) | 1.08 | 2.8e-05 | 0.000672 |
GO:0098573 | intrinsic component of mitochondrial membrane | 4.6% (4/87) | 4.53 | 2.9e-05 | 0.000685 |
GO:1901564 | organonitrogen compound metabolic process | 41.38% (36/87) | 0.93 | 3.1e-05 | 0.000709 |
GO:0043167 | ion binding | 36.78% (32/87) | 1.02 | 3e-05 | 0.000713 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 8.05% (7/87) | 2.99 | 3e-05 | 0.000714 |
GO:0015918 | sterol transport | 4.6% (4/87) | 4.49 | 3.2e-05 | 0.000731 |
GO:1903684 | regulation of border follicle cell migration | 3.45% (3/87) | 5.59 | 3.4e-05 | 0.000757 |
GO:1903688 | positive regulation of border follicle cell migration | 3.45% (3/87) | 5.59 | 3.4e-05 | 0.000757 |
GO:0099523 | presynaptic cytosol | 3.45% (3/87) | 5.54 | 3.7e-05 | 0.000836 |
GO:0042995 | cell projection | 13.79% (12/87) | 2.01 | 4e-05 | 0.000883 |
GO:0006807 | nitrogen compound metabolic process | 48.28% (42/87) | 0.79 | 4.4e-05 | 0.000974 |
GO:0016740 | transferase activity | 32.18% (28/87) | 1.09 | 4.8e-05 | 0.00105 |
GO:2000463 | positive regulation of excitatory postsynaptic potential | 2.3% (2/87) | 7.49 | 4.9e-05 | 0.001057 |
GO:0005768 | endosome | 13.79% (12/87) | 1.98 | 5e-05 | 0.001074 |
GO:0019538 | protein metabolic process | 29.89% (26/87) | 1.15 | 5.1e-05 | 0.001088 |
GO:0000139 | Golgi membrane | 9.2% (8/87) | 2.61 | 5.2e-05 | 0.00109 |
GO:0044087 | regulation of cellular component biogenesis | 10.34% (9/87) | 2.4 | 5.3e-05 | 0.00111 |
GO:0035613 | RNA stem-loop binding | 3.45% (3/87) | 5.35 | 5.5e-05 | 0.001153 |
GO:0140096 | catalytic activity, acting on a protein | 25.29% (22/87) | 1.29 | 5.6e-05 | 0.001159 |
GO:0030334 | regulation of cell migration | 6.9% (6/87) | 3.17 | 5.8e-05 | 0.001195 |
GO:0098787 | mRNA cleavage involved in mRNA processing | 3.45% (3/87) | 5.31 | 6.1e-05 | 0.001224 |
GO:0098789 | pre-mRNA cleavage required for polyadenylation | 3.45% (3/87) | 5.31 | 6.1e-05 | 0.001224 |
GO:0051223 | regulation of protein transport | 6.9% (6/87) | 3.14 | 6.4e-05 | 0.00128 |
GO:0046903 | secretion | 6.9% (6/87) | 3.14 | 6.5e-05 | 0.001284 |
GO:2000145 | regulation of cell motility | 6.9% (6/87) | 3.14 | 6.5e-05 | 0.001284 |
GO:0042147 | retrograde transport, endosome to Golgi | 4.6% (4/87) | 4.17 | 7.6e-05 | 0.001495 |
GO:0106310 | protein serine kinase activity | 8.05% (7/87) | 2.77 | 7.9e-05 | 0.001509 |
GO:0008266 | poly(U) RNA binding | 4.6% (4/87) | 4.15 | 7.9e-05 | 0.00151 |
GO:0005703 | polytene chromosome puff | 3.45% (3/87) | 5.19 | 7.8e-05 | 0.001513 |
GO:0060135 | maternal process involved in female pregnancy | 3.45% (3/87) | 5.19 | 7.8e-05 | 0.001513 |
GO:0006612 | protein targeting to membrane | 4.6% (4/87) | 4.14 | 8.2e-05 | 0.001557 |
GO:0048278 | vesicle docking | 3.45% (3/87) | 5.15 | 8.5e-05 | 0.001594 |
GO:0010632 | regulation of epithelial cell migration | 4.6% (4/87) | 4.11 | 8.9e-05 | 0.001656 |
GO:0008187 | poly-pyrimidine tract binding | 4.6% (4/87) | 4.1 | 9.2e-05 | 0.001707 |
GO:0007041 | lysosomal transport | 4.6% (4/87) | 4.08 | 9.6e-05 | 0.001758 |
GO:2000070 | regulation of response to water deprivation | 6.9% (6/87) | 3.03 | 9.8e-05 | 0.001796 |
GO:0065008 | regulation of biological quality | 26.44% (23/87) | 1.2 | 0.000101 | 0.001826 |
GO:0032555 | purine ribonucleotide binding | 18.39% (16/87) | 1.54 | 0.000105 | 0.001892 |
GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding | 3.45% (3/87) | 5.04 | 0.000107 | 0.001911 |
GO:0017076 | purine nucleotide binding | 18.39% (16/87) | 1.53 | 0.000113 | 0.002012 |
GO:0022402 | cell cycle process | 13.79% (12/87) | 1.85 | 0.000118 | 0.002085 |
GO:0008152 | metabolic process | 59.77% (52/87) | 0.59 | 0.000123 | 0.002124 |
GO:0006379 | mRNA cleavage | 3.45% (3/87) | 4.97 | 0.000123 | 0.002133 |
GO:0034046 | poly(G) binding | 3.45% (3/87) | 4.97 | 0.000123 | 0.002133 |
GO:0099522 | cytosolic region | 3.45% (3/87) | 4.97 | 0.000123 | 0.002133 |
GO:0070201 | regulation of establishment of protein localization | 6.9% (6/87) | 2.96 | 0.000127 | 0.002176 |
GO:0043065 | positive regulation of apoptotic process | 5.75% (5/87) | 3.37 | 0.000131 | 0.00223 |
GO:0072658 | maintenance of protein location in membrane | 2.3% (2/87) | 6.81 | 0.000136 | 0.002265 |
GO:0072660 | maintenance of protein location in plasma membrane | 2.3% (2/87) | 6.81 | 0.000136 | 0.002265 |
GO:0050896 | response to stimulus | 58.62% (51/87) | 0.6 | 0.000134 | 0.002267 |
GO:0043170 | macromolecule metabolic process | 40.23% (35/87) | 0.85 | 0.000137 | 0.002275 |
GO:0048864 | stem cell development | 3.45% (3/87) | 4.9 | 0.000141 | 0.002324 |
GO:0032553 | ribonucleotide binding | 18.39% (16/87) | 1.5 | 0.000144 | 0.00236 |
GO:0015631 | tubulin binding | 6.9% (6/87) | 2.92 | 0.000149 | 0.002416 |
GO:0035639 | purine ribonucleoside triphosphate binding | 17.24% (15/87) | 1.55 | 0.000157 | 0.002544 |
GO:0098685 | Schaffer collateral - CA1 synapse | 3.45% (3/87) | 4.84 | 0.000161 | 0.002568 |
GO:0005484 | SNAP receptor activity | 3.45% (3/87) | 4.84 | 0.000161 | 0.002568 |
GO:0006887 | exocytosis | 4.6% (4/87) | 3.87 | 0.00017 | 0.002695 |
GO:0043412 | macromolecule modification | 26.44% (23/87) | 1.14 | 0.000175 | 0.002719 |
GO:1902683 | regulation of receptor localization to synapse | 2.3% (2/87) | 6.64 | 0.000175 | 0.002721 |
GO:0071285 | cellular response to lithium ion | 2.3% (2/87) | 6.64 | 0.000175 | 0.002721 |
GO:0031581 | hemidesmosome assembly | 2.3% (2/87) | 6.64 | 0.000175 | 0.002721 |
GO:0048588 | developmental cell growth | 10.34% (9/87) | 2.16 | 0.000186 | 0.002872 |
GO:0044238 | primary metabolic process | 50.57% (44/87) | 0.67 | 0.000219 | 0.003312 |
GO:1900064 | positive regulation of peroxisome organization | 2.3% (2/87) | 6.49 | 0.000218 | 0.003318 |
GO:0040012 | regulation of locomotion | 6.9% (6/87) | 2.82 | 0.000217 | 0.003329 |
GO:1903047 | mitotic cell cycle process | 9.2% (8/87) | 2.3 | 0.000225 | 0.003394 |
GO:0071216 | cellular response to biotic stimulus | 4.6% (4/87) | 3.75 | 0.000236 | 0.003531 |
GO:0043186 | P granule | 3.45% (3/87) | 4.62 | 0.000257 | 0.003827 |
GO:0051051 | negative regulation of transport | 5.75% (5/87) | 3.14 | 0.000267 | 0.003885 |
GO:0009134 | nucleoside diphosphate catabolic process | 2.3% (2/87) | 6.35 | 0.000266 | 0.003894 |
GO:0098815 | modulation of excitatory postsynaptic potential | 2.3% (2/87) | 6.35 | 0.000266 | 0.003894 |
GO:0007465 | R7 cell fate commitment | 2.3% (2/87) | 6.35 | 0.000266 | 0.003894 |
GO:0019048 | modulation by virus of host process | 3.45% (3/87) | 4.59 | 0.000271 | 0.003928 |
GO:0097367 | carbohydrate derivative binding | 18.39% (16/87) | 1.41 | 0.000273 | 0.003932 |
GO:0008654 | phospholipid biosynthetic process | 5.75% (5/87) | 3.12 | 0.000286 | 0.004106 |
GO:0022414 | reproductive process | 33.33% (29/87) | 0.92 | 0.000292 | 0.004164 |
GO:1902115 | regulation of organelle assembly | 4.6% (4/87) | 3.66 | 0.000294 | 0.004171 |
GO:0006796 | phosphate-containing compound metabolic process | 20.69% (18/87) | 1.29 | 0.000299 | 0.004219 |
GO:0140040 | mitochondrial polycistronic RNA processing | 2.3% (2/87) | 6.23 | 0.000319 | 0.004333 |
GO:0001752 | compound eye photoreceptor fate commitment | 2.3% (2/87) | 6.23 | 0.000319 | 0.004333 |
GO:0042706 | eye photoreceptor cell fate commitment | 2.3% (2/87) | 6.23 | 0.000319 | 0.004333 |
GO:0046552 | photoreceptor cell fate commitment | 2.3% (2/87) | 6.23 | 0.000319 | 0.004333 |
GO:0016281 | eukaryotic translation initiation factor 4F complex | 2.3% (2/87) | 6.23 | 0.000319 | 0.004333 |
GO:0000910 | cytokinesis | 5.75% (5/87) | 3.09 | 0.000313 | 0.00439 |
GO:2000785 | regulation of autophagosome assembly | 3.45% (3/87) | 4.51 | 0.000316 | 0.004416 |
GO:0044003 | modulation by symbiont of host process | 3.45% (3/87) | 4.47 | 0.000349 | 0.004677 |
GO:0031201 | SNARE complex | 3.45% (3/87) | 4.47 | 0.000349 | 0.004677 |
GO:1903829 | positive regulation of protein localization | 5.75% (5/87) | 3.06 | 0.000347 | 0.004694 |
GO:0090575 | RNA polymerase II transcription regulator complex | 4.6% (4/87) | 3.58 | 0.000362 | 0.004827 |
GO:0033365 | protein localization to organelle | 9.2% (8/87) | 2.19 | 0.000369 | 0.004852 |
GO:0007017 | microtubule-based process | 9.2% (8/87) | 2.2 | 0.000366 | 0.004859 |
GO:0006793 | phosphorus metabolic process | 20.69% (18/87) | 1.27 | 0.000368 | 0.00486 |
GO:1900063 | regulation of peroxisome organization | 2.3% (2/87) | 6.11 | 0.000376 | 0.004913 |
GO:0005773 | vacuole | 13.79% (12/87) | 1.66 | 0.000398 | 0.00517 |
GO:0046470 | phosphatidylcholine metabolic process | 3.45% (3/87) | 4.4 | 0.000402 | 0.005206 |
GO:0046474 | glycerophospholipid biosynthetic process | 4.6% (4/87) | 3.54 | 0.00041 | 0.00528 |
GO:0005849 | mRNA cleavage factor complex | 3.45% (3/87) | 4.37 | 0.000421 | 0.005371 |
GO:0048026 | positive regulation of mRNA splicing, via spliceosome | 3.45% (3/87) | 4.37 | 0.000421 | 0.005371 |
GO:0045182 | translation regulator activity | 5.75% (5/87) | 3.0 | 0.000423 | 0.005373 |
GO:0032501 | multicellular organismal process | 33.33% (29/87) | 0.89 | 0.00043 | 0.005436 |
GO:1902473 | regulation of protein localization to synapse | 2.3% (2/87) | 6.0 | 0.000438 | 0.005456 |
GO:0017110 | nucleoside diphosphate phosphatase activity | 2.3% (2/87) | 6.0 | 0.000438 | 0.005456 |
GO:0048663 | neuron fate commitment | 2.3% (2/87) | 6.0 | 0.000438 | 0.005456 |
GO:0035556 | intracellular signal transduction | 11.49% (10/87) | 1.85 | 0.000441 | 0.005471 |
GO:0008017 | microtubule binding | 5.75% (5/87) | 2.97 | 0.000459 | 0.00566 |
GO:0005886 | plasma membrane | 27.59% (24/87) | 1.01 | 0.000471 | 0.00579 |
GO:0019904 | protein domain specific binding | 8.05% (7/87) | 2.34 | 0.000477 | 0.005833 |
GO:0005844 | polysome | 3.45% (3/87) | 4.31 | 0.000481 | 0.005852 |
GO:0005739 | mitochondrion | 14.94% (13/87) | 1.54 | 0.000483 | 0.005857 |
GO:0046753 | non-lytic viral release | 2.3% (2/87) | 5.9 | 0.000505 | 0.006087 |
GO:0140352 | export from cell | 6.9% (6/87) | 2.59 | 0.000512 | 0.006149 |
GO:0032509 | endosome transport via multivesicular body sorting pathway | 3.45% (3/87) | 4.27 | 0.000523 | 0.006174 |
GO:0071985 | multivesicular body sorting pathway | 3.45% (3/87) | 4.27 | 0.000523 | 0.006174 |
GO:0044088 | regulation of vacuole organization | 3.45% (3/87) | 4.27 | 0.000523 | 0.006174 |
GO:0071248 | cellular response to metal ion | 4.6% (4/87) | 3.45 | 0.000519 | 0.006203 |
GO:0007034 | vacuolar transport | 5.75% (5/87) | 2.92 | 0.000536 | 0.006266 |
GO:0030163 | protein catabolic process | 8.05% (7/87) | 2.32 | 0.000534 | 0.006275 |
GO:0030371 | translation repressor activity | 3.45% (3/87) | 4.25 | 0.000546 | 0.006352 |
GO:0008047 | enzyme activator activity | 5.75% (5/87) | 2.91 | 0.000552 | 0.006403 |
GO:0090385 | phagosome-lysosome fusion | 2.3% (2/87) | 5.81 | 0.000576 | 0.006646 |
GO:0033157 | regulation of intracellular protein transport | 4.6% (4/87) | 3.4 | 0.00058 | 0.006669 |
GO:0050685 | positive regulation of mRNA processing | 3.45% (3/87) | 4.21 | 0.000592 | 0.006743 |
GO:0032507 | maintenance of protein location in cell | 3.45% (3/87) | 4.21 | 0.000592 | 0.006743 |
GO:0005815 | microtubule organizing center | 6.9% (6/87) | 2.54 | 0.000608 | 0.006898 |
GO:0048589 | developmental growth | 13.79% (12/87) | 1.58 | 0.000627 | 0.007084 |
GO:0042171 | lysophosphatidic acid acyltransferase activity | 2.3% (2/87) | 5.72 | 0.000652 | 0.007239 |
GO:0030695 | GTPase regulator activity | 4.6% (4/87) | 3.36 | 0.000647 | 0.007246 |
GO:0060589 | nucleoside-triphosphatase regulator activity | 4.6% (4/87) | 3.36 | 0.000647 | 0.007246 |
GO:0005813 | centrosome | 5.75% (5/87) | 2.86 | 0.00065 | 0.007255 |
GO:0043547 | positive regulation of GTPase activity | 3.45% (3/87) | 4.15 | 0.000666 | 0.007365 |
GO:0035821 | modulation of process of another organism | 3.45% (3/87) | 4.13 | 0.000692 | 0.007588 |
GO:0010821 | regulation of mitochondrion organization | 3.45% (3/87) | 4.13 | 0.000692 | 0.007588 |
GO:0061709 | reticulophagy | 2.3% (2/87) | 5.64 | 0.000732 | 0.007934 |
GO:0007319 | negative regulation of oskar mRNA translation | 2.3% (2/87) | 5.64 | 0.000732 | 0.007934 |
GO:0046011 | regulation of oskar mRNA translation | 2.3% (2/87) | 5.64 | 0.000732 | 0.007934 |
GO:0045185 | maintenance of protein location | 3.45% (3/87) | 4.09 | 0.000745 | 0.008044 |
GO:0034248 | regulation of cellular amide metabolic process | 8.05% (7/87) | 2.23 | 0.000753 | 0.008093 |
GO:0006644 | phospholipid metabolic process | 6.9% (6/87) | 2.47 | 0.000765 | 0.008193 |
GO:0030335 | positive regulation of cell migration | 4.6% (4/87) | 3.28 | 0.000796 | 0.008488 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 2.3% (2/87) | 5.56 | 0.000817 | 0.008576 |
GO:0098837 | postsynaptic recycling endosome | 2.3% (2/87) | 5.56 | 0.000817 | 0.008576 |
GO:0050804 | modulation of chemical synaptic transmission | 4.6% (4/87) | 3.27 | 0.000812 | 0.008591 |
GO:0099177 | regulation of trans-synaptic signaling | 4.6% (4/87) | 3.27 | 0.000812 | 0.008591 |
GO:2000147 | positive regulation of cell motility | 4.6% (4/87) | 3.26 | 0.000828 | 0.008661 |
GO:0031122 | cytoplasmic microtubule organization | 4.6% (4/87) | 3.24 | 0.000879 | 0.009152 |
GO:0043168 | anion binding | 19.54% (17/87) | 1.21 | 0.000892 | 0.009254 |
GO:0051345 | positive regulation of hydrolase activity | 4.6% (4/87) | 3.23 | 0.000896 | 0.00926 |
GO:0071704 | organic substance metabolic process | 54.02% (47/87) | 0.55 | 0.0009 | 0.009266 |
GO:0043495 | protein-membrane adaptor activity | 2.3% (2/87) | 5.49 | 0.000907 | 0.009295 |
GO:0033120 | positive regulation of RNA splicing | 3.45% (3/87) | 3.99 | 0.000922 | 0.009382 |
GO:0032456 | endocytic recycling | 3.45% (3/87) | 3.99 | 0.000922 | 0.009382 |
GO:0001505 | regulation of neurotransmitter levels | 3.45% (3/87) | 3.97 | 0.000954 | 0.009668 |
GO:0044237 | cellular metabolic process | 50.57% (44/87) | 0.58 | 0.000971 | 0.009805 |
GO:0031902 | late endosome membrane | 3.45% (3/87) | 3.95 | 0.000986 | 0.009922 |
GO:0071617 | lysophospholipid acyltransferase activity | 2.3% (2/87) | 5.42 | 0.001 | 0.009953 |
GO:0031644 | regulation of nervous system process | 2.3% (2/87) | 5.42 | 0.001 | 0.009953 |
GO:0007044 | cell-substrate junction assembly | 2.3% (2/87) | 5.42 | 0.001 | 0.009953 |
GO:0000166 | nucleotide binding | 21.84% (19/87) | 1.1 | 0.001009 | 0.009963 |
GO:1901265 | nucleoside phosphate binding | 21.84% (19/87) | 1.1 | 0.001009 | 0.009963 |
GO:0007032 | endosome organization | 3.45% (3/87) | 3.94 | 0.001019 | 0.009992 |
GO:0023051 | regulation of signaling | 18.39% (16/87) | 1.24 | 0.001019 | 0.01002 |
GO:0010628 | positive regulation of gene expression | 9.2% (8/87) | 1.97 | 0.001038 | 0.010133 |
GO:0005798 | Golgi-associated vesicle | 3.45% (3/87) | 3.92 | 0.001053 | 0.010249 |
GO:0051235 | maintenance of location | 4.6% (4/87) | 3.15 | 0.001102 | 0.010535 |
GO:0010646 | regulation of cell communication | 18.39% (16/87) | 1.23 | 0.001099 | 0.01054 |
GO:0005457 | GDP-fucose transmembrane transporter activity | 2.3% (2/87) | 5.35 | 0.001099 | 0.010577 |
GO:0036080 | purine nucleotide-sugar transmembrane transporter activity | 2.3% (2/87) | 5.35 | 0.001099 | 0.010577 |
GO:0022607 | cellular component assembly | 16.09% (14/87) | 1.34 | 0.001111 | 0.010583 |
GO:0003824 | catalytic activity | 49.43% (43/87) | 0.58 | 0.001093 | 0.010599 |
GO:1902936 | phosphatidylinositol bisphosphate binding | 3.45% (3/87) | 3.89 | 0.001123 | 0.010618 |
GO:0098978 | glutamatergic synapse | 4.6% (4/87) | 3.15 | 0.001123 | 0.010652 |
GO:0008092 | cytoskeletal protein binding | 8.05% (7/87) | 2.12 | 0.001161 | 0.010934 |
GO:0016049 | cell growth | 12.64% (11/87) | 1.57 | 0.00118 | 0.011073 |
GO:0071786 | endoplasmic reticulum tubular network organization | 2.3% (2/87) | 5.29 | 0.001202 | 0.011164 |
GO:0046337 | phosphatidylethanolamine metabolic process | 2.3% (2/87) | 5.29 | 0.001202 | 0.011164 |
GO:0098845 | postsynaptic endosome | 2.3% (2/87) | 5.29 | 0.001202 | 0.011164 |
GO:0048764 | trichoblast maturation | 3.45% (3/87) | 3.84 | 0.001233 | 0.011338 |
GO:0048765 | root hair cell differentiation | 3.45% (3/87) | 3.84 | 0.001233 | 0.011338 |
GO:0040017 | positive regulation of locomotion | 4.6% (4/87) | 3.11 | 0.001228 | 0.011368 |
GO:0055067 | monovalent inorganic cation homeostasis | 5.75% (5/87) | 2.65 | 0.001253 | 0.011479 |
GO:0005096 | GTPase activator activity | 3.45% (3/87) | 3.81 | 0.00131 | 0.011924 |
GO:0015783 | GDP-fucose transmembrane transport | 2.3% (2/87) | 5.23 | 0.001309 | 0.011953 |
GO:0070717 | poly-purine tract binding | 3.45% (3/87) | 3.8 | 0.00135 | 0.012243 |
GO:0000149 | SNARE binding | 3.45% (3/87) | 3.78 | 0.001391 | 0.012524 |
GO:0099003 | vesicle-mediated transport in synapse | 3.45% (3/87) | 3.78 | 0.001391 | 0.012524 |
GO:0030865 | cortical cytoskeleton organization | 4.6% (4/87) | 3.06 | 0.001411 | 0.012662 |
GO:0032367 | intracellular cholesterol transport | 2.3% (2/87) | 5.17 | 0.001421 | 0.01267 |
GO:0008568 | microtubule severing ATPase activity | 2.3% (2/87) | 5.17 | 0.001421 | 0.01267 |
GO:0000922 | spindle pole | 3.45% (3/87) | 3.75 | 0.001474 | 0.013095 |
GO:0010498 | proteasomal protein catabolic process | 6.9% (6/87) | 2.29 | 0.001497 | 0.013263 |
GO:0090480 | purine nucleotide-sugar transmembrane transport | 2.3% (2/87) | 5.11 | 0.001537 | 0.013437 |
GO:0150115 | cell-substrate junction organization | 2.3% (2/87) | 5.11 | 0.001537 | 0.013437 |
GO:0060560 | developmental growth involved in morphogenesis | 11.49% (10/87) | 1.62 | 0.001524 | 0.01345 |
GO:1901000 | regulation of response to salt stress | 5.75% (5/87) | 2.58 | 0.001536 | 0.013516 |
GO:0009860 | pollen tube growth | 6.9% (6/87) | 2.27 | 0.001596 | 0.013902 |
GO:0048639 | positive regulation of developmental growth | 4.6% (4/87) | 3.0 | 0.001611 | 0.013992 |
GO:0045017 | glycerolipid biosynthetic process | 4.6% (4/87) | 3.0 | 0.001638 | 0.014175 |
GO:1904375 | regulation of protein localization to cell periphery | 3.45% (3/87) | 3.7 | 0.001649 | 0.014227 |
GO:0015850 | organic hydroxy compound transport | 4.6% (4/87) | 2.97 | 0.001746 | 0.015018 |
GO:0000226 | microtubule cytoskeleton organization | 6.9% (6/87) | 2.24 | 0.00176 | 0.015037 |
GO:0031306 | intrinsic component of mitochondrial outer membrane | 2.3% (2/87) | 5.0 | 0.001783 | 0.01504 |
GO:0031307 | integral component of mitochondrial outer membrane | 2.3% (2/87) | 5.0 | 0.001783 | 0.01504 |
GO:0019054 | modulation by virus of host cellular process | 2.3% (2/87) | 5.0 | 0.001783 | 0.01504 |
GO:0004707 | MAP kinase activity | 2.3% (2/87) | 5.0 | 0.001783 | 0.01504 |
GO:0065009 | regulation of molecular function | 13.79% (12/87) | 1.41 | 0.001755 | 0.015043 |
GO:1903530 | regulation of secretion by cell | 4.6% (4/87) | 2.95 | 0.001831 | 0.015351 |
GO:1900180 | regulation of protein localization to nucleus | 3.45% (3/87) | 3.64 | 0.001837 | 0.015351 |
GO:0019637 | organophosphate metabolic process | 10.34% (9/87) | 1.7 | 0.001828 | 0.015372 |
GO:0006869 | lipid transport | 5.75% (5/87) | 2.52 | 0.001864 | 0.01553 |
GO:0048869 | cellular developmental process | 17.24% (15/87) | 1.21 | 0.001876 | 0.015577 |
GO:0031324 | negative regulation of cellular metabolic process | 14.94% (13/87) | 1.33 | 0.001889 | 0.015594 |
GO:0017156 | calcium-ion regulated exocytosis | 2.3% (2/87) | 4.95 | 0.001912 | 0.015636 |
GO:0044068 | modulation by symbiont of host cellular process | 2.3% (2/87) | 4.95 | 0.001912 | 0.015636 |
GO:0047262 | polygalacturonate 4-alpha-galacturonosyltransferase activity | 2.3% (2/87) | 4.95 | 0.001912 | 0.015636 |
GO:0030674 | protein-macromolecule adaptor activity | 4.6% (4/87) | 2.94 | 0.001889 | 0.01564 |
GO:0051651 | maintenance of location in cell | 3.45% (3/87) | 3.62 | 0.001936 | 0.015781 |
GO:0007275 | multicellular organism development | 16.09% (14/87) | 1.25 | 0.002004 | 0.01629 |
GO:0005654 | nucleoplasm | 12.64% (11/87) | 1.47 | 0.002017 | 0.016345 |
GO:0090407 | organophosphate biosynthetic process | 6.9% (6/87) | 2.2 | 0.002038 | 0.016417 |
GO:0007049 | cell cycle | 6.9% (6/87) | 2.2 | 0.002038 | 0.016417 |
GO:0000819 | sister chromatid segregation | 2.3% (2/87) | 4.9 | 0.002046 | 0.016427 |
GO:0099080 | supramolecular complex | 9.2% (8/87) | 1.81 | 0.002072 | 0.016591 |
GO:0071782 | endoplasmic reticulum tubular network | 3.45% (3/87) | 3.58 | 0.00209 | 0.016681 |
GO:0010508 | positive regulation of autophagy | 3.45% (3/87) | 3.56 | 0.002143 | 0.017054 |
GO:0016081 | synaptic vesicle docking | 1.15% (1/87) | 8.81 | 0.002226 | 0.01715 |
GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter | 1.15% (1/87) | 8.81 | 0.002226 | 0.01715 |
GO:0098967 | exocytic insertion of neurotransmitter receptor to postsynaptic membrane | 1.15% (1/87) | 8.81 | 0.002226 | 0.01715 |
GO:0150003 | regulation of spontaneous synaptic transmission | 1.15% (1/87) | 8.81 | 0.002226 | 0.01715 |
GO:1903422 | negative regulation of synaptic vesicle recycling | 1.15% (1/87) | 8.81 | 0.002226 | 0.01715 |
GO:1904048 | regulation of spontaneous neurotransmitter secretion | 1.15% (1/87) | 8.81 | 0.002226 | 0.01715 |
GO:1904050 | positive regulation of spontaneous neurotransmitter secretion | 1.15% (1/87) | 8.81 | 0.002226 | 0.01715 |
GO:0000147 | actin cortical patch assembly | 1.15% (1/87) | 8.81 | 0.002226 | 0.01715 |
GO:0061630 | ubiquitin protein ligase activity | 5.75% (5/87) | 2.47 | 0.00217 | 0.017221 |
GO:0010226 | response to lithium ion | 2.3% (2/87) | 4.86 | 0.002184 | 0.017223 |
GO:0051013 | microtubule severing | 2.3% (2/87) | 4.86 | 0.002184 | 0.017223 |
GO:0017157 | regulation of exocytosis | 3.45% (3/87) | 3.53 | 0.002307 | 0.017674 |
GO:0055080 | cation homeostasis | 8.05% (7/87) | 1.95 | 0.002305 | 0.01771 |
GO:0019076 | viral release from host cell | 2.3% (2/87) | 4.81 | 0.002326 | 0.017716 |
GO:0070861 | regulation of protein exit from endoplasmic reticulum | 2.3% (2/87) | 4.81 | 0.002326 | 0.017716 |
GO:0061659 | ubiquitin-like protein ligase activity | 5.75% (5/87) | 2.44 | 0.002361 | 0.017934 |
GO:0006650 | glycerophospholipid metabolic process | 4.6% (4/87) | 2.85 | 0.0024 | 0.018176 |
GO:0045121 | membrane raft | 3.45% (3/87) | 3.5 | 0.002421 | 0.018283 |
GO:0040007 | growth | 13.79% (12/87) | 1.35 | 0.002429 | 0.018292 |
GO:0097435 | supramolecular fiber organization | 5.75% (5/87) | 2.43 | 0.002436 | 0.018292 |
GO:0098857 | membrane microdomain | 3.45% (3/87) | 3.49 | 0.002479 | 0.018307 |
GO:0090158 | endoplasmic reticulum membrane organization | 2.3% (2/87) | 4.77 | 0.002472 | 0.018308 |
GO:0035891 | exit from host cell | 2.3% (2/87) | 4.77 | 0.002472 | 0.018308 |
GO:0099643 | signal release from synapse | 2.3% (2/87) | 4.77 | 0.002472 | 0.018308 |
GO:0051046 | regulation of secretion | 4.6% (4/87) | 2.83 | 0.00247 | 0.018444 |
GO:0003727 | single-stranded RNA binding | 4.6% (4/87) | 2.83 | 0.002505 | 0.01845 |
GO:0008289 | lipid binding | 6.9% (6/87) | 2.14 | 0.002467 | 0.018472 |
GO:0051247 | positive regulation of protein metabolic process | 9.2% (8/87) | 1.76 | 0.002518 | 0.018493 |
GO:0042802 | identical protein binding | 17.24% (15/87) | 1.16 | 0.002525 | 0.018496 |
GO:0006468 | protein phosphorylation | 11.49% (10/87) | 1.52 | 0.002575 | 0.018805 |
GO:1900181 | negative regulation of protein localization to nucleus | 2.3% (2/87) | 4.72 | 0.002623 | 0.0189 |
GO:0046928 | regulation of neurotransmitter secretion | 2.3% (2/87) | 4.72 | 0.002623 | 0.0189 |
GO:0051588 | regulation of neurotransmitter transport | 2.3% (2/87) | 4.72 | 0.002623 | 0.0189 |
GO:0140776 | protein-containing complex destabilizing activity | 2.3% (2/87) | 4.72 | 0.002623 | 0.0189 |
GO:0048469 | cell maturation | 3.45% (3/87) | 3.47 | 0.002598 | 0.018922 |
GO:0000902 | cell morphogenesis | 11.49% (10/87) | 1.51 | 0.00267 | 0.019188 |
GO:0045927 | positive regulation of growth | 5.75% (5/87) | 2.4 | 0.002697 | 0.019223 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 8.05% (7/87) | 1.91 | 0.002691 | 0.019231 |
GO:0034976 | response to endoplasmic reticulum stress | 4.6% (4/87) | 2.8 | 0.002688 | 0.019263 |
GO:0030154 | cell differentiation | 12.64% (11/87) | 1.41 | 0.002717 | 0.019315 |
GO:0007010 | cytoskeleton organization | 8.05% (7/87) | 1.9 | 0.002744 | 0.019407 |
GO:0000904 | cell morphogenesis involved in differentiation | 9.2% (8/87) | 1.74 | 0.002744 | 0.019456 |
GO:0032366 | intracellular sterol transport | 2.3% (2/87) | 4.68 | 0.002778 | 0.019592 |
GO:0006417 | regulation of translation | 6.9% (6/87) | 2.1 | 0.002802 | 0.019713 |
GO:0016787 | hydrolase activity | 20.69% (18/87) | 1.01 | 0.002825 | 0.019823 |
GO:0050807 | regulation of synapse organization | 3.45% (3/87) | 3.41 | 0.00291 | 0.020255 |
GO:1905475 | regulation of protein localization to membrane | 3.45% (3/87) | 3.41 | 0.00291 | 0.020255 |
GO:0048487 | beta-tubulin binding | 2.3% (2/87) | 4.64 | 0.002937 | 0.020338 |
GO:0036258 | multivesicular body assembly | 2.3% (2/87) | 4.64 | 0.002937 | 0.020338 |
GO:0032559 | adenyl ribonucleotide binding | 13.79% (12/87) | 1.32 | 0.002909 | 0.020354 |
GO:1903532 | positive regulation of secretion by cell | 3.45% (3/87) | 3.4 | 0.002975 | 0.020494 |
GO:0009719 | response to endogenous stimulus | 22.99% (20/87) | 0.94 | 0.002971 | 0.020523 |
GO:0051246 | regulation of protein metabolic process | 13.79% (12/87) | 1.31 | 0.003043 | 0.020696 |
GO:0043087 | regulation of GTPase activity | 3.45% (3/87) | 3.39 | 0.003041 | 0.020734 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 3.45% (3/87) | 3.39 | 0.003041 | 0.020734 |
GO:0030554 | adenyl nucleotide binding | 13.79% (12/87) | 1.32 | 0.003032 | 0.020777 |
GO:0055065 | metal ion homeostasis | 6.9% (6/87) | 2.08 | 0.003029 | 0.020813 |
GO:0051047 | positive regulation of secretion | 3.45% (3/87) | 3.37 | 0.003108 | 0.021083 |
GO:0051716 | cellular response to stimulus | 26.44% (23/87) | 0.84 | 0.003135 | 0.021213 |
GO:0071345 | cellular response to cytokine stimulus | 4.6% (4/87) | 2.73 | 0.003163 | 0.021348 |
GO:0036094 | small molecule binding | 21.84% (19/87) | 0.96 | 0.003187 | 0.021454 |
GO:0032386 | regulation of intracellular transport | 4.6% (4/87) | 2.72 | 0.003247 | 0.021698 |
GO:0090068 | positive regulation of cell cycle process | 4.6% (4/87) | 2.72 | 0.003247 | 0.021698 |
GO:0052546 | cell wall pectin metabolic process | 3.45% (3/87) | 3.35 | 0.003244 | 0.021786 |
GO:0003924 | GTPase activity | 4.6% (4/87) | 2.72 | 0.00329 | 0.021929 |
GO:0061912 | selective autophagy | 2.3% (2/87) | 4.53 | 0.00344 | 0.022811 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.3% (2/87) | 4.53 | 0.00344 | 0.022811 |
GO:1902584 | positive regulation of response to water deprivation | 3.45% (3/87) | 3.32 | 0.003456 | 0.022861 |
GO:0031426 | polycistronic mRNA processing | 2.3% (2/87) | 4.49 | 0.003615 | 0.023115 |
GO:0007009 | plasma membrane organization | 2.3% (2/87) | 4.49 | 0.003615 | 0.023115 |
GO:0045639 | positive regulation of myeloid cell differentiation | 2.3% (2/87) | 4.49 | 0.003615 | 0.023115 |
GO:0045773 | positive regulation of axon extension | 2.3% (2/87) | 4.49 | 0.003615 | 0.023115 |
GO:0048168 | regulation of neuronal synaptic plasticity | 2.3% (2/87) | 4.49 | 0.003615 | 0.023115 |
GO:0044703 | multi-organism reproductive process | 2.3% (2/87) | 4.49 | 0.003615 | 0.023115 |
GO:0036257 | multivesicular body organization | 2.3% (2/87) | 4.49 | 0.003615 | 0.023115 |
GO:0051336 | regulation of hydrolase activity | 5.75% (5/87) | 2.29 | 0.003635 | 0.023184 |
GO:0043068 | positive regulation of programmed cell death | 5.75% (5/87) | 2.3 | 0.003535 | 0.023214 |
GO:0047484 | regulation of response to osmotic stress | 5.75% (5/87) | 2.3 | 0.003535 | 0.023214 |
GO:0048731 | system development | 9.2% (8/87) | 1.68 | 0.003518 | 0.023218 |
GO:0005774 | vacuolar membrane | 12.64% (11/87) | 1.36 | 0.003702 | 0.023444 |
GO:0043228 | non-membrane-bounded organelle | 18.39% (16/87) | 1.06 | 0.0037 | 0.023485 |
GO:0043232 | intracellular non-membrane-bounded organelle | 18.39% (16/87) | 1.06 | 0.0037 | 0.023485 |
GO:0060255 | regulation of macromolecule metabolic process | 27.59% (24/87) | 0.8 | 0.003603 | 0.023488 |
GO:0009826 | unidimensional cell growth | 9.2% (8/87) | 1.68 | 0.003614 | 0.0235 |
GO:0051348 | negative regulation of transferase activity | 3.45% (3/87) | 3.3 | 0.003601 | 0.023532 |
GO:0060090 | molecular adaptor activity | 4.6% (4/87) | 2.68 | 0.0036 | 0.023584 |
GO:0051962 | positive regulation of nervous system development | 3.45% (3/87) | 3.28 | 0.003751 | 0.023694 |
GO:0098930 | axonal transport | 2.3% (2/87) | 4.45 | 0.003795 | 0.023808 |
GO:0009932 | cell tip growth | 6.9% (6/87) | 2.01 | 0.003792 | 0.02384 |
GO:0098687 | chromosomal region | 4.6% (4/87) | 2.66 | 0.003786 | 0.023863 |
GO:0098771 | inorganic ion homeostasis | 8.05% (7/87) | 1.81 | 0.00386 | 0.02416 |
GO:0043622 | cortical microtubule organization | 3.45% (3/87) | 3.26 | 0.003904 | 0.024372 |
GO:0005811 | lipid droplet | 3.45% (3/87) | 3.25 | 0.003981 | 0.0248 |
GO:0010540 | basipetal auxin transport | 3.45% (3/87) | 3.24 | 0.00406 | 0.025233 |
GO:0044089 | positive regulation of cellular component biogenesis | 4.6% (4/87) | 2.63 | 0.004127 | 0.025588 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 2.3% (2/87) | 4.39 | 0.004168 | 0.025601 |
GO:0019882 | antigen processing and presentation | 2.3% (2/87) | 4.39 | 0.004168 | 0.025601 |
GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 2.3% (2/87) | 4.39 | 0.004168 | 0.025601 |
GO:0099638 | endosome to plasma membrane protein transport | 2.3% (2/87) | 4.39 | 0.004168 | 0.025601 |
GO:0071618 | lysophosphatidylethanolamine acyltransferase activity | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:0031584 | activation of phospholipase D activity | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:0045504 | dynein heavy chain binding | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:0032797 | SMN complex | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:0051725 | protein de-ADP-ribosylation | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:0140291 | peptidyl-glutamate ADP-deribosylation | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:0140293 | ADP-ribosylglutamate hydrolase activity | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:0007120 | axial cellular bud site selection | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:1902684 | negative regulation of receptor localization to synapse | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:0036017 | response to erythropoietin | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:0036018 | cellular response to erythropoietin | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:0071282 | cellular response to iron(II) ion | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:1990418 | response to insulin-like growth factor stimulus | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:1990478 | response to ultrasound | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:0036152 | phosphatidylethanolamine acyl-chain remodeling | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:0070292 | N-acylphosphatidylethanolamine metabolic process | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:0008864 | formyltetrahydrofolate deformylase activity | 1.15% (1/87) | 7.81 | 0.004447 | 0.025997 |
GO:0071363 | cellular response to growth factor stimulus | 3.45% (3/87) | 3.19 | 0.004469 | 0.02607 |
GO:0090317 | negative regulation of intracellular protein transport | 2.3% (2/87) | 4.32 | 0.004556 | 0.026462 |
GO:0032266 | phosphatidylinositol-3-phosphate binding | 2.3% (2/87) | 4.32 | 0.004556 | 0.026462 |
GO:1901363 | heterocyclic compound binding | 37.93% (33/87) | 0.62 | 0.004344 | 0.026621 |
GO:0010822 | positive regulation of mitochondrion organization | 2.3% (2/87) | 4.35 | 0.00436 | 0.026658 |
GO:0031267 | small GTPase binding | 3.45% (3/87) | 3.2 | 0.004385 | 0.026692 |
GO:1901981 | phosphatidylinositol phosphate binding | 3.45% (3/87) | 3.2 | 0.004385 | 0.026692 |
GO:0003006 | developmental process involved in reproduction | 25.29% (22/87) | 0.83 | 0.004399 | 0.026714 |
GO:0000373 | Group II intron splicing | 2.3% (2/87) | 4.29 | 0.004756 | 0.027446 |
GO:0010148 | transpiration | 2.3% (2/87) | 4.29 | 0.004756 | 0.027446 |
GO:1902751 | positive regulation of cell cycle G2/M phase transition | 2.3% (2/87) | 4.29 | 0.004756 | 0.027446 |
GO:0005524 | ATP binding | 12.64% (11/87) | 1.31 | 0.004777 | 0.027507 |
GO:0097159 | organic cyclic compound binding | 37.93% (33/87) | 0.61 | 0.004866 | 0.027957 |
GO:0042391 | regulation of membrane potential | 3.45% (3/87) | 3.14 | 0.004901 | 0.028041 |
GO:0070848 | response to growth factor | 3.45% (3/87) | 3.14 | 0.004901 | 0.028041 |
GO:0005794 | Golgi apparatus | 10.34% (9/87) | 1.48 | 0.005044 | 0.028736 |
GO:0030427 | site of polarized growth | 4.6% (4/87) | 2.54 | 0.00504 | 0.028772 |
GO:0005525 | GTP binding | 4.6% (4/87) | 2.54 | 0.005097 | 0.028976 |
GO:1900458 | negative regulation of brassinosteroid mediated signaling pathway | 2.3% (2/87) | 4.23 | 0.005169 | 0.029318 |
GO:0010033 | response to organic substance | 29.89% (26/87) | 0.72 | 0.005346 | 0.030258 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 2.3% (2/87) | 4.2 | 0.005381 | 0.030328 |
GO:0007080 | mitotic metaphase plate congression | 2.3% (2/87) | 4.2 | 0.005381 | 0.030328 |
GO:0030135 | coated vesicle | 3.45% (3/87) | 3.07 | 0.005548 | 0.031205 |
GO:0032365 | intracellular lipid transport | 2.3% (2/87) | 4.17 | 0.005597 | 0.031347 |
GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 2.3% (2/87) | 4.17 | 0.005597 | 0.031347 |
GO:0055075 | potassium ion homeostasis | 3.45% (3/87) | 3.07 | 0.005644 | 0.031547 |
GO:0010562 | positive regulation of phosphorus metabolic process | 4.6% (4/87) | 2.49 | 0.005698 | 0.031711 |
GO:0045937 | positive regulation of phosphate metabolic process | 4.6% (4/87) | 2.49 | 0.005698 | 0.031711 |
GO:0019222 | regulation of metabolic process | 31.03% (27/87) | 0.69 | 0.005732 | 0.031835 |
GO:0004842 | ubiquitin-protein transferase activity | 6.9% (6/87) | 1.89 | 0.005771 | 0.031919 |
GO:0015931 | nucleobase-containing compound transport | 4.6% (4/87) | 2.49 | 0.00576 | 0.031926 |
GO:0008270 | zinc ion binding | 6.9% (6/87) | 1.88 | 0.005923 | 0.032624 |
GO:0030054 | cell junction | 18.39% (16/87) | 0.99 | 0.005915 | 0.032648 |
GO:0042981 | regulation of apoptotic process | 6.9% (6/87) | 1.88 | 0.006 | 0.032981 |
GO:0032387 | negative regulation of intracellular transport | 2.3% (2/87) | 4.11 | 0.006041 | 0.033138 |
GO:0015234 | thiamine transmembrane transporter activity | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0015888 | thiamine transport | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0030974 | thiamine pyrophosphate transmembrane transport | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0071934 | thiamine transmembrane transport | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0090422 | thiamine pyrophosphate transmembrane transporter activity | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0044790 | suppression of viral release by host | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0044791 | obsolete positive regulation by host of viral release from host cell | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0046725 | negative regulation by virus of viral protein levels in host cell | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0005858 | axonemal dynein complex | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0032795 | heterotrimeric G-protein binding | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0036156 | inner dynein arm | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0030277 | maintenance of gastrointestinal epithelium | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0048644 | muscle organ morphogenesis | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0000282 | cellular bud site selection | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0007114 | cell budding | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0032505 | reproduction of a single-celled organism | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0000320 | re-entry into mitotic cell cycle | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0014043 | negative regulation of neuron maturation | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0033690 | positive regulation of osteoblast proliferation | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0034392 | negative regulation of smooth muscle cell apoptotic process | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0035733 | hepatic stellate cell activation | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0045672 | positive regulation of osteoclast differentiation | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0046849 | bone remodeling | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0090289 | regulation of osteoclast proliferation | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0090290 | positive regulation of osteoclast proliferation | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:1990776 | response to angiotensin | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:1903850 | regulation of cristae formation | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:1903852 | positive regulation of cristae formation | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0071783 | endoplasmic reticulum cisternal network organization | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0071784 | endoplasmic reticulum cisternal network assembly | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0048787 | presynaptic active zone membrane | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0016189 | synaptic vesicle to endosome fusion | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:1900060 | negative regulation of ceramide biosynthetic process | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:1904221 | negative regulation of serine C-palmitoyltransferase activity | 1.15% (1/87) | 7.23 | 0.006663 | 0.033139 |
GO:0080090 | regulation of primary metabolic process | 26.44% (23/87) | 0.77 | 0.006092 | 0.033352 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 6.9% (6/87) | 1.87 | 0.006117 | 0.033417 |
GO:0006892 | post-Golgi vesicle-mediated transport | 3.45% (3/87) | 2.97 | 0.006771 | 0.033616 |
GO:0019941 | modification-dependent protein catabolic process | 6.9% (6/87) | 1.86 | 0.006275 | 0.034004 |
GO:0005338 | nucleotide-sugar transmembrane transporter activity | 2.3% (2/87) | 4.08 | 0.006269 | 0.034038 |
GO:0050772 | positive regulation of axonogenesis | 2.3% (2/87) | 4.08 | 0.006269 | 0.034038 |
GO:0051310 | metaphase plate congression | 2.3% (2/87) | 4.08 | 0.006269 | 0.034038 |
GO:0007163 | establishment or maintenance of cell polarity | 3.45% (3/87) | 3.0 | 0.006347 | 0.034116 |
GO:0032886 | regulation of microtubule-based process | 3.45% (3/87) | 3.0 | 0.006347 | 0.034116 |
GO:0019787 | ubiquitin-like protein transferase activity | 6.9% (6/87) | 1.83 | 0.006897 | 0.034175 |
GO:0030003 | cellular cation homeostasis | 5.75% (5/87) | 2.1 | 0.006328 | 0.034222 |
GO:0004672 | protein kinase activity | 11.49% (10/87) | 1.33 | 0.006346 | 0.03425 |
GO:0005667 | transcription regulator complex | 4.6% (4/87) | 2.45 | 0.00641 | 0.034386 |
GO:0032561 | guanyl ribonucleotide binding | 4.6% (4/87) | 2.41 | 0.006964 | 0.034447 |
GO:0098827 | endoplasmic reticulum subcompartment | 3.45% (3/87) | 2.95 | 0.006989 | 0.034506 |
GO:0098876 | vesicle-mediated transport to the plasma membrane | 3.45% (3/87) | 3.0 | 0.006452 | 0.034538 |
GO:0010564 | regulation of cell cycle process | 6.9% (6/87) | 1.85 | 0.006478 | 0.034608 |
GO:0007029 | endoplasmic reticulum organization | 2.3% (2/87) | 4.06 | 0.006501 | 0.034661 |
GO:0012505 | endomembrane system | 5.75% (5/87) | 2.09 | 0.00653 | 0.034748 |
GO:0010942 | positive regulation of cell death | 5.75% (5/87) | 2.06 | 0.007054 | 0.03476 |
GO:0070647 | protein modification by small protein conjugation or removal | 9.2% (8/87) | 1.51 | 0.007081 | 0.034831 |
GO:0071241 | cellular response to inorganic substance | 4.6% (4/87) | 2.4 | 0.007108 | 0.034832 |
GO:0006813 | potassium ion transport | 3.45% (3/87) | 2.95 | 0.0071 | 0.034858 |
GO:0099513 | polymeric cytoskeletal fiber | 5.75% (5/87) | 2.09 | 0.006581 | 0.03495 |
GO:0043005 | neuron projection | 5.75% (5/87) | 2.06 | 0.007216 | 0.035044 |
GO:0014069 | postsynaptic density | 3.45% (3/87) | 2.94 | 0.007211 | 0.035084 |
GO:0099572 | postsynaptic specialization | 3.45% (3/87) | 2.94 | 0.007211 | 0.035084 |
GO:0019001 | guanyl nucleotide binding | 4.6% (4/87) | 2.4 | 0.00718 | 0.035122 |
GO:0098796 | membrane protein complex | 6.9% (6/87) | 1.82 | 0.007201 | 0.035162 |
GO:0009725 | response to hormone | 20.69% (18/87) | 0.88 | 0.007367 | 0.035712 |
GO:0043632 | modification-dependent macromolecule catabolic process | 6.9% (6/87) | 1.81 | 0.007425 | 0.035925 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 2.3% (2/87) | 3.95 | 0.007466 | 0.035993 |
GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway | 2.3% (2/87) | 3.95 | 0.007466 | 0.035993 |
GO:0045489 | pectin biosynthetic process | 3.45% (3/87) | 2.9 | 0.007669 | 0.036903 |
GO:0015780 | nucleotide-sugar transmembrane transport | 2.3% (2/87) | 3.93 | 0.007717 | 0.037002 |
GO:0050801 | ion homeostasis | 8.05% (7/87) | 1.63 | 0.007707 | 0.037022 |
GO:0034097 | response to cytokine | 4.6% (4/87) | 2.36 | 0.007777 | 0.037221 |
GO:0042592 | homeostatic process | 12.64% (11/87) | 1.21 | 0.007851 | 0.037509 |
GO:2001233 | regulation of apoptotic signaling pathway | 3.45% (3/87) | 2.89 | 0.007903 | 0.037626 |
GO:0051020 | GTPase binding | 3.45% (3/87) | 2.89 | 0.007903 | 0.037626 |
GO:0045055 | regulated exocytosis | 2.3% (2/87) | 3.9 | 0.007972 | 0.037681 |
GO:0030148 | sphingolipid biosynthetic process | 2.3% (2/87) | 3.9 | 0.007972 | 0.037681 |
GO:0019899 | enzyme binding | 12.64% (11/87) | 1.21 | 0.00793 | 0.037685 |
GO:0006873 | cellular ion homeostasis | 5.75% (5/87) | 2.02 | 0.007952 | 0.037723 |
GO:1900457 | regulation of brassinosteroid mediated signaling pathway | 3.45% (3/87) | 2.88 | 0.008022 | 0.037854 |
GO:0099081 | supramolecular polymer | 5.75% (5/87) | 2.01 | 0.008129 | 0.038154 |
GO:0099512 | supramolecular fiber | 5.75% (5/87) | 2.01 | 0.008129 | 0.038154 |
GO:0048468 | cell development | 6.9% (6/87) | 1.78 | 0.008126 | 0.038274 |
GO:0050790 | regulation of catalytic activity | 9.2% (8/87) | 1.47 | 0.008177 | 0.038313 |
GO:1901216 | positive regulation of neuron death | 2.3% (2/87) | 3.88 | 0.00823 | 0.038425 |
GO:0034329 | cell junction assembly | 2.3% (2/87) | 3.88 | 0.00823 | 0.038425 |
GO:0044828 | negative regulation by host of viral genome replication | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0090114 | COPII-coated vesicle budding | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:1990447 | U2 snRNP binding | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0060124 | positive regulation of growth hormone secretion | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0033688 | regulation of osteoblast proliferation | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0044026 | DNA hypermethylation | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0044027 | hypermethylation of CpG island | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0045886 | negative regulation of synaptic assembly at neuromuscular junction | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0050774 | negative regulation of dendrite morphogenesis | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0051964 | negative regulation of synapse assembly | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0061049 | cell growth involved in cardiac muscle cell development | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0072537 | fibroblast activation | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:1904397 | negative regulation of neuromuscular junction development | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:2001222 | regulation of neuron migration | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:2001223 | negative regulation of neuron migration | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0002538 | arachidonic acid metabolite production involved in inflammatory response | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0002539 | prostaglandin production involved in inflammatory response | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0033885 | 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0043651 | linoleic acid metabolic process | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0019087 | transformation of host cell by virus | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:1904577 | obsolete cellular response to tunicamycin | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:1990826 | nucleoplasmic periphery of the nuclear pore complex | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0010620 | negative regulation of transcription by transcription factor catabolism | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0033344 | cholesterol efflux | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0032468 | Golgi calcium ion homeostasis | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0032472 | Golgi calcium ion transport | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:1903724 | positive regulation of centriole elongation | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:1903774 | positive regulation of viral budding via host ESCRT complex | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0060903 | positive regulation of meiosis I | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:1904220 | regulation of serine C-palmitoyltransferase activity | 1.15% (1/87) | 6.81 | 0.008874 | 0.038974 |
GO:0005543 | phospholipid binding | 4.6% (4/87) | 2.31 | 0.008897 | 0.039014 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 3.45% (3/87) | 2.86 | 0.008386 | 0.039084 |
GO:0023057 | negative regulation of signaling | 9.2% (8/87) | 1.45 | 0.008963 | 0.039173 |
GO:0033993 | response to lipid | 17.24% (15/87) | 0.96 | 0.008955 | 0.039202 |
GO:0010648 | negative regulation of cell communication | 9.2% (8/87) | 1.45 | 0.009041 | 0.039255 |
GO:0044057 | regulation of system process | 3.45% (3/87) | 2.82 | 0.009012 | 0.03926 |
GO:1990573 | potassium ion import across plasma membrane | 2.3% (2/87) | 3.81 | 0.009027 | 0.039261 |
GO:0010941 | regulation of cell death | 9.2% (8/87) | 1.45 | 0.009002 | 0.039278 |
GO:0052325 | cell wall pectin biosynthetic process | 2.3% (2/87) | 3.86 | 0.008492 | 0.039511 |
GO:0051050 | positive regulation of transport | 5.75% (5/87) | 1.97 | 0.009183 | 0.039744 |
GO:0016567 | protein ubiquitination | 8.05% (7/87) | 1.58 | 0.009182 | 0.039806 |
GO:0006643 | membrane lipid metabolic process | 3.45% (3/87) | 2.8 | 0.009271 | 0.040057 |
GO:0048027 | mRNA 5'-UTR binding | 2.3% (2/87) | 3.79 | 0.009301 | 0.040122 |
GO:0048878 | chemical homeostasis | 11.49% (10/87) | 1.26 | 0.008645 | 0.040152 |
GO:0048524 | positive regulation of viral process | 2.3% (2/87) | 3.83 | 0.008758 | 0.040535 |
GO:0032268 | regulation of cellular protein metabolic process | 2.3% (2/87) | 3.83 | 0.008758 | 0.040535 |
GO:1903900 | regulation of viral life cycle | 2.3% (2/87) | 3.77 | 0.009577 | 0.041117 |
GO:0009892 | negative regulation of metabolic process | 16.09% (14/87) | 1.0 | 0.009565 | 0.04113 |
GO:0009966 | regulation of signal transduction | 14.94% (13/87) | 1.05 | 0.009558 | 0.041168 |
GO:0008283 | cell population proliferation | 3.45% (3/87) | 2.78 | 0.009666 | 0.041429 |
GO:0005789 | endoplasmic reticulum membrane | 8.05% (7/87) | 1.56 | 0.009733 | 0.041651 |
GO:0010556 | regulation of macromolecule biosynthetic process | 19.54% (17/87) | 0.87 | 0.009798 | 0.041862 |
GO:0008088 | axo-dendritic transport | 2.3% (2/87) | 3.75 | 0.009858 | 0.041916 |
GO:0023061 | signal release | 2.3% (2/87) | 3.75 | 0.009858 | 0.041916 |
GO:0098813 | nuclear chromosome segregation | 2.3% (2/87) | 3.75 | 0.009858 | 0.041916 |
GO:0006875 | cellular metal ion homeostasis | 4.6% (4/87) | 2.25 | 0.010119 | 0.042958 |
GO:0033149 | FFAT motif binding | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0036498 | IRE1-mediated unfolded protein response | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0002505 | antigen processing and presentation of polysaccharide antigen via MHC class II | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0002747 | antigen processing and presentation following phagocytosis | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0007431 | salivary gland development | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0046754 | viral exocytosis | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0090117 | endosome to lysosome transport of low-density lipoprotein particle | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0090119 | vesicle-mediated cholesterol transport | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0099054 | presynapse assembly | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0101004 | cytolytic granule membrane | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:1902774 | late endosome to lysosome transport | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:1990027 | S bouton | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:1990927 | calcium ion regulated lysosome exocytosis | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0071942 | XPC complex | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0032769 | negative regulation of monooxygenase activity | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0050999 | regulation of nitric-oxide synthase activity | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0097284 | hepatocyte apoptotic process | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0098696 | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:2000171 | negative regulation of dendrite development | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:2000725 | regulation of cardiac muscle cell differentiation | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:2000727 | positive regulation of cardiac muscle cell differentiation | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0004105 | choline-phosphate cytidylyltransferase activity | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0042564 | NLS-dependent protein nuclear import complex | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:1904116 | response to vasopressin | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0045760 | positive regulation of action potential | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0036369 | transcription factor catabolic process | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0017040 | N-acylsphingosine amidohydrolase activity | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0031082 | BLOC complex | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0031083 | BLOC-1 complex | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0046601 | positive regulation of centriole replication | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:1903772 | regulation of viral budding via host ESCRT complex | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:1990621 | ESCRT IV complex | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0090155 | negative regulation of sphingolipid biosynthetic process | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:2000303 | regulation of ceramide biosynthetic process | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0102485 | obsolete dATP phosphohydrolase activity | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0102486 | obsolete dCTP phosphohydrolase activity | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0102487 | obsolete dUTP phosphohydrolase activity | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0102488 | obsolete dTTP phosphohydrolase activity | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0102489 | obsolete GTP phosphohydrolase activity | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0102490 | obsolete 8-oxo-dGTP phosphohydrolase activity | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0102491 | obsolete dGTP phosphohydrolase activity | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:1905443 | regulation of clathrin coat assembly | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:1905445 | positive regulation of clathrin coat assembly | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:1990175 | EH domain binding | 1.15% (1/87) | 6.49 | 0.01108 | 0.04306 |
GO:0048585 | negative regulation of response to stimulus | 12.64% (11/87) | 1.15 | 0.010312 | 0.043639 |
GO:0046486 | glycerolipid metabolic process | 4.6% (4/87) | 2.25 | 0.010302 | 0.043665 |
GO:0045787 | positive regulation of cell cycle | 4.6% (4/87) | 2.24 | 0.010487 | 0.04403 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 11.49% (10/87) | 1.2 | 0.01135 | 0.044043 |
GO:0090615 | mitochondrial mRNA processing | 2.3% (2/87) | 3.7 | 0.01043 | 0.044067 |
GO:0016310 | phosphorylation | 11.49% (10/87) | 1.22 | 0.010468 | 0.044086 |
GO:0035091 | phosphatidylinositol binding | 3.45% (3/87) | 2.74 | 0.010486 | 0.044093 |
GO:0010608 | post-transcriptional regulation of gene expression | 6.9% (6/87) | 1.7 | 0.010456 | 0.044108 |
GO:0010053 | root epidermal cell differentiation | 3.45% (3/87) | 2.73 | 0.010626 | 0.044543 |
GO:0051224 | negative regulation of protein transport | 2.3% (2/87) | 3.62 | 0.011617 | 0.045015 |
GO:0043067 | regulation of programmed cell death | 8.05% (7/87) | 1.51 | 0.011637 | 0.04503 |
GO:0048513 | animal organ development | 8.05% (7/87) | 1.51 | 0.011799 | 0.045587 |
GO:0031323 | regulation of cellular metabolic process | 26.44% (23/87) | 0.7 | 0.01096 | 0.045872 |
GO:0030516 | regulation of axon extension | 2.3% (2/87) | 3.6 | 0.011922 | 0.045932 |
GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding | 2.3% (2/87) | 3.6 | 0.011922 | 0.045932 |
GO:0031901 | early endosome membrane | 2.3% (2/87) | 3.66 | 0.011016 | 0.046033 |
GO:0032446 | protein modification by small protein conjugation | 8.05% (7/87) | 1.52 | 0.011061 | 0.046146 |
GO:0003729 | mRNA binding | 10.34% (9/87) | 1.28 | 0.011998 | 0.046155 |
GO:0051656 | establishment of organelle localization | 4.6% (4/87) | 2.18 | 0.012046 | 0.046274 |
GO:0030010 | establishment of cell polarity | 2.3% (2/87) | 3.58 | 0.012231 | 0.04692 |
GO:1903313 | positive regulation of mRNA metabolic process | 3.45% (3/87) | 2.65 | 0.012397 | 0.047486 |
GO:0042221 | response to chemical | 35.63% (31/87) | 0.55 | 0.012426 | 0.047531 |
GO:0030133 | transport vesicle | 3.45% (3/87) | 2.64 | 0.012552 | 0.047941 |
GO:0030004 | cellular monovalent inorganic cation homeostasis | 3.45% (3/87) | 2.63 | 0.012708 | 0.048398 |
GO:0030100 | regulation of endocytosis | 3.45% (3/87) | 2.63 | 0.012708 | 0.048398 |
GO:0045117 | azole transmembrane transport | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:0140268 | endoplasmic reticulum-plasma membrane contact site | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:1903292 | protein localization to Golgi membrane | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:0070390 | transcription export complex 2 | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:0048209 | regulation of vesicle targeting, to, from or within Golgi | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:0080119 | ER body organization | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:0010669 | epithelial structure maintenance | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:0035372 | protein localization to microtubule | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:0045670 | regulation of osteoclast differentiation | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:1903430 | negative regulation of cell maturation | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:1905809 | negative regulation of synapse organization | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:1900030 | regulation of pectin biosynthetic process | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:0031074 | nucleocytoplasmic transport complex | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:0033592 | RNA strand annealing activity | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:0060858 | vesicle-mediated transport involved in floral organ abscission | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:0006940 | regulation of smooth muscle contraction | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:0061744 | motor behavior | 1.15% (1/87) | 6.23 | 0.013281 | 0.048704 |
GO:0051960 | regulation of nervous system development | 3.45% (3/87) | 2.63 | 0.012865 | 0.048786 |
GO:0035618 | root hair | 2.3% (2/87) | 3.54 | 0.01286 | 0.048839 |
GO:0051303 | establishment of chromosome localization | 2.3% (2/87) | 3.54 | 0.01286 | 0.048839 |
GO:0009889 | regulation of biosynthetic process | 21.84% (19/87) | 0.77 | 0.012917 | 0.048916 |
GO:0009926 | auxin polar transport | 3.45% (3/87) | 2.62 | 0.013023 | 0.049246 |
GO:0051603 | proteolysis involved in protein catabolic process | 6.9% (6/87) | 1.63 | 0.013092 | 0.04944 |
GO:1904950 | negative regulation of establishment of protein localization | 2.3% (2/87) | 3.51 | 0.013503 | 0.049448 |
GO:0009737 | response to abscisic acid | 10.34% (9/87) | 1.25 | 0.013117 | 0.049464 |
GO:0044000 | movement in host | 2.3% (2/87) | 3.53 | 0.01318 | 0.049489 |
GO:0006446 | regulation of translational initiation | 2.3% (2/87) | 3.53 | 0.01318 | 0.049489 |
GO:0061951 | establishment of protein localization to plasma membrane | 2.3% (2/87) | 3.53 | 0.01318 | 0.049489 |